Your browser doesn't support javascript.
loading
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.
Tull, Thomas J; Benton, Emma C; Semkova, Kristina; Watson, Natalie A; Mee, John B; Lopez, Begona; Setterfield, Jane; Carey, Barbara; Ahmad, Sajjad; Robbie, Scott J; Groves, Richard W; Sanna, Giovanni; D'Cruz, David P.
Afiliação
  • Tull TJ; St John's Institute of Dermatology.
  • Benton EC; St John's Institute of Dermatology.
  • Semkova K; St John's Institute of Dermatology.
  • Watson NA; Ear, Nose and Throat Department.
  • Mee JB; St John's Institute of Dermatology.
  • Lopez B; Louise Coote Lupus Unit.
  • Setterfield J; St John's Institute of Dermatology.
  • Carey B; St John's Institute of Dermatology.
  • Ahmad S; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Robbie SJ; Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust.
  • Groves RW; St John's Institute of Dermatology.
  • Sanna G; Louise Coote Lupus Unit.
  • D'Cruz DP; Louise Coote Lupus Unit.
Br J Dermatol ; 191(1): 138-140, 2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38561894
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioterapia Combinada / Anticorpos Monoclonais Humanizados / Rituximab / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioterapia Combinada / Anticorpos Monoclonais Humanizados / Rituximab / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2024 Tipo de documento: Article